Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Rheumatoid Arthritis

Free Subscription Articles published in J Rheumatol Retrieve available abstracts of 98 articles: HTML format

Single Articles

October 2025
1. ARA AF, Chenoweth M, Kadiyala S, Essien UR, et al
   Racial and Ethnic Disparities in Disease-Modifying Antirheumatic Drug Use Among Adults With Rheumatoid Arthritis in the United States.
   J Rheumatol. 2025 Oct 1:jrheum.2025-0290. doi: 10.3899/jrheum.2025-0290.
   PubMed    
   
   
   September 2025
2. ESTER M, Dhiman K, Githumbi R, Sipley M, et al
   Priority Setting of Physical Activity Barriers and Facilitators Among Individuals With Rheumatoid Arthritis: A Nominal Group Technique Study.
   J Rheumatol. 2025 Sep 15:jrheum.2025-0191.C1. doi: 10.3899/jrheum.2025-0191.
   PubMed     Abstract available
   
   
   
3. JOERNS EK, Lopez-Ruiz A, Lennon RJ, Crowson CS, et al
   Differences in Cause-Specific Mortality in Patients with Rheumatoid Arthritis by Sex and Seropositivity.
   J Rheumatol. 2025 Sep 15:jrheum.2025-0361. doi: 10.3899/jrheum.2025-0361.
   PubMed     Abstract available
   
   
   
4. BANINA MC, Prabhune R, Charles C, Colmegna I, et al
   Understanding patient and physician perspectives regarding innovative research in rheumatoid arthritis.
   J Rheumatol. 2025 Sep 15:jrheum.2025-0510. doi: 10.3899/jrheum.2025-0510.
   PubMed     Abstract available
   
   
   
5. KHIDIR SJH, van Mulligen E, van der Helm-van Mil AHM
   Identifying resolution of clinically suspect arthralgia: a step towards understanding spontaneous reversal of an at-risk stage of rheumatoid arthritis.
   J Rheumatol. 2025 Sep 1:jrheum.2025-0052. doi: 10.3899/jrheum.2025-0052.
   PubMed     Abstract available
   
   
   
6. BARDAN I, Uhlig T, Sexton J, Kvien TK, et al
   Health-related Quality of Life in DMARD-treated adults with Juvenile Idiopathic Arthritis Compared to Rheumatoid Arthritis and the General Population.
   J Rheumatol. 2025 Sep 1:jrheum.2025-0384. doi: 10.3899/jrheum.2025-0384.
   PubMed     Abstract available
   
   
   
7. BEYDON M, Nguyen Y, Gordon R, Foulquier N, et al
   A Systematic Review of Clinical Trial Designs and Outcome Measures in Sjogren Disease Randomized Controlled Trials.
   J Rheumatol. 2025;52:858-872.
   PubMed     Abstract available
   
   
   August 2025
8. SAUVE E, Barnabe C
   The Usual Suspects: Established and Emerging Predictor Variables for Remission in Rheumatoid Arthritis.
   J Rheumatol. 2025 Aug 15:jrheum.2025-0476. doi: 10.3899/jrheum.2025-0476.
   PubMed     Abstract available
   
   
   
9. YAMADA S, Azuma T
   Multiple Hematoma, Purpura, and Ulcers in a Patient With Rheumatoid Arthritis.
   J Rheumatol. 2025 Aug 1:jrheum.2025-0516. doi: 10.3899/jrheum.2025-0516.
   PubMed    
   
   
   
10. TOUSSIROT E, Ramon A, Laheurte C, Gravelin E, et al
    Analysis of Gut-Homing Receptors in Circulating Mucosal-Associated Invariant T Cells and Their Presence in Synovial Tissue From Patients With Axial Spondyloarthritis.
    J Rheumatol. 2025;52:770-778.
    PubMed     Abstract available
    
    
    July 2025
11. BROOKS RT, Hulshizer CA, Hanson AC, Davis JM 3rd, et al
    Cumulative Incidence of Cancer Screening for Breast, Cervical, Prostate, and Colorectal Cancer in Patients with Rheumatoid Arthritis.
    J Rheumatol. 2025 Jul 25:jrheum.2025-0190. doi: 10.3899/jrheum.2025-0190.
    PubMed     Abstract available
    
    
    
12. ESTER M, Dhiman K, Githumbi R, Sipley M, et al
    Priority setting of physical activity barriers and facilitators among individuals with rheumatoid arthritis: a nominal group technique study.
    J Rheumatol. 2025 Jul 25:jrheum.2025-0191. doi: 10.3899/jrheum.2025-0191.
    PubMed     Abstract available
    
    
    
13. LAI SW
    Herpes Zoster Vaccine and Rheumatoid Arthritis.
    J Rheumatol. 2025 Jul 1:jrheum.2025-0272. doi: 10.3899/jrheum.2025-0272.
    PubMed    
    
    
    
14. TAMAI H, Ito S, Takanashi S, Kondo Y, et al
    Achievement and Usefulness of Intermediate Treatment Targets for Still Disease Proposed by the European Alliance of Associations for Rheumatology and the Paediatric Rheumatology European Society.
    J Rheumatol. 2025;52:662-668.
    PubMed     Abstract available
    
    
    
15. GAMA CR, Franco AS, Bortoluzzo AB, Miossi R, et al
    Characteristics of Overlap Syndrome in a Large Cohort of Brazilian Patients With Systemic Sclerosis: A Retrospective Analysis.
    J Rheumatol. 2025;52:693-698.
    PubMed     Abstract available
    
    
    June 2025
16. SUKKAR MB, Ainley R, Barrett C, Bond S, et al
    Development of the Australian Rheumatology Association Clinical Care Standard for the diagnosis and management of rheumatoid arthritis in adults.
    J Rheumatol. 2025 Jun 1:jrheum.2024-1034. doi: 10.3899/jrheum.2024-1034.
    PubMed     Abstract available
    
    
    May 2025
17. GJERTSSON I, Aurell Y, Rudin A, Hultgard Ekwall AK, et al
    Cone beam computed tomography for assessment of erosions in early rheumatoid arthritis - a pilot study.
    J Rheumatol. 2025 May 15:jrheum.2024-1276. doi: 10.3899/jrheum.2024-1276.
    PubMed     Abstract available
    
    
    
18. PATTERSON SL, Ruvalcaba D, Issa A, Rai K, et al
    Experiences with Complementary and Integrative Health Among People with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Qualitative Study.
    J Rheumatol. 2025 May 1:jrheum.2024-1218. doi: 10.3899/jrheum.2024-1218.
    PubMed     Abstract available
    
    
    
19. KOPPIKAR S, Kuriya B, Udell JA, Yu B, et al
    Risk of Heart Failure in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Study.
    J Rheumatol. 2025;52:489-497.
    PubMed     Abstract available
    
    
    April 2025
20. RAZMJOU AA, Pham A, Volkmann ER, Ranganath VK, et al
    Survival After Lung Transplantation in Patients With Rheumatoid Arthritis-Associated Lung Disease.
    J Rheumatol. 2025 Apr 15:jrheum.2025-0025. doi: 10.3899/jrheum.2025-0025.
    PubMed    
    
    
    
21. GITHUMBI R, Katz SJ, Widdifield J, Barber CEH, et al
    Update to a Systematic Review on Quality Measures for Rheumatoid Arthritis.
    J Rheumatol. 2025 Apr 15:jrheum.2024-1314. doi: 10.3899/jrheum.2024-1314.
    PubMed     Abstract available
    
    
    
22. KELLY CA, Shaikh M
    Practical Issues Relating to the Use of Antifibrotic Therapy in Patients With Interstitial Lung Disease and Rheumatoid Arthritis.
    J Rheumatol. 2025 Apr 1:jrheum.2025-0103. doi: 10.3899/jrheum.2025-0103.
    PubMed    
    
    
    
23. SINGH JA, Chandrupatla SR
    Rural-dwelling patients with rheumatoid arthritis have higher risk of myocardial infarction hospitalization: an observational study using the National Inpatient Sample.
    J Rheumatol. 2025 Apr 1:jrheum.2024-1036. doi: 10.3899/jrheum.2024-1036.
    PubMed     Abstract available
    
    
    March 2025
24. KOC GH, Looijen AEM, van der Horst-Bruinsma IE, de Jong PHP, et al
    Sex Differences in Rheumatoid Arthritis: New Insights from clinical and patient-reported outcome perspective.
    J Rheumatol. 2025 Mar 1:jrheum.2024-1258. doi: 10.3899/jrheum.2024-1258.
    PubMed     Abstract available
    
    
    
25. MOVAHEDI M, Cesta A, Li X, Tatangelo M, et al
    Health Care Utilization and Cost of Herpes Zoster Infection in Patients with Rheumatoid Arthritis, a Retrospective Cohort Study.
    J Rheumatol. 2025 Mar 1:jrheum.2024-0911. doi: 10.3899/jrheum.2024-0911.
    PubMed     Abstract available
    
    
    
26. WANG G, Liu Z
    Association Between Rheumatoid Arthritis and Ambulatory Blood Pressure.
    J Rheumatol. 2025 Mar 1:jrheum.2024-1292. doi: 10.3899/jrheum.2024-1292.
    PubMed    
    
    
    
27. ROUMEN C, Hochstenbach LM, van den Dungen P, Knops AM, et al
    Development of an application for self-monitoring to empower patients with rheumatoid arthritis (MyRA).
    J Rheumatol. 2025 Mar 1:jrheum.2024-1071. doi: 10.3899/jrheum.2024-1071.
    PubMed     Abstract available
    
    
    
28. LOVGACH OR, Plaza Z, Castro MF, Rosas J, et al
    Mortality in Patients With Sjogren Disease: A Prospective Cohort Study Identifying Key Predictors.
    J Rheumatol. 2025;52:257-262.
    PubMed     Abstract available
    
    
    February 2025
29. CAPELUSNIK D, Ramiro S, Nikiphorou E, Maksymowych WP, et al
    Unacceptable work state in rheumatoid arthritis: establishment of thresholds for presenteeism and clinical measurement instruments.
    J Rheumatol. 2025 Feb 1:jrheum.2024-0833. doi: 10.3899/jrheum.2024-0833.
    PubMed     Abstract available
    
    
    
30. ROJAS-SERRANO J
    Progressive Pulmonary Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    J Rheumatol. 2025 Feb 1:jrheum.2024-1333. doi: 10.3899/jrheum.2024-1333.
    PubMed    
    
    
    January 2025
31. CHANG SH, Park YB, McDermott GC, Paudel ML, et al
    Serum Biomarkers of Pulmonary Damage and Risk for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    J Rheumatol. 2025 Jan 15:jrheum.2024-0713. doi: 10.3899/jrheum.2024-0713.
    PubMed     Abstract available
    
    
    
32. EDWARDS CJ, Kronke G, Avouac J, Li Z, et al
    Baricitinib dose reduction in patients with rheumatoid arthritis achieving sustained disease control: Final results from the RA-BEYOND study.
    J Rheumatol. 2025 Jan 15:jrheum.2024-0906. doi: 10.3899/jrheum.2024-0906.
    PubMed     Abstract available
    
    
    
33. EMERY P, Fleischmann R, Wong R, Lozenski K, et al
    Association between abatacept exposure levels and infection occurrence in patients with rheumatoid arthritis: post hoc analysis of the AVERT-2 study.
    J Rheumatol. 2025 Jan 15:jrheum.2024-0498. doi: 10.3899/jrheum.2024-0498.
    PubMed     Abstract available
    
    
    
34. CASO F, Giacomelli R, Nunziato M, Di Maggio F, et al
    The Reshaping of Modifiable Risk Factors as a Strategy to Prevent the Development of Rheumatoid Arthritis.
    J Rheumatol. 2025 Jan 15:jrheum.2024-0545. doi: 10.3899/jrheum.2024-0545.
    PubMed    
    
    
    
35. SWEET N, Huang H, Bartels CM
    Mind Matters in Rheumatoid Arthritis: The Rising Burden of Anxiety and Depression.
    J Rheumatol. 2025 Jan 15:jrheum.2024-1273. doi: 10.3899/jrheum.2024-1273.
    PubMed    
    
    
    December 2024
36. SEBASTIANI M, Lepri G, Iannone C, Cassione EB, et al
    Nintedanib in rheumatoid arthritis related interstitial lung disease: real-world safety profile and risk of side effects and discontinuation.
    J Rheumatol. 2024 Dec 15:jrheum.2024-0976. doi: 10.3899/jrheum.2024-0976.
    PubMed     Abstract available
    
    
    
37. WANG G, Liu Z
    High-Sensitivity Cardiac Troponin T as a Marker to Improve Cardiovascular Disease Risk Assessment Among Patients With Rheumatoid Arthritis.
    J Rheumatol. 2024 Dec 15:jrheum.2024-0723. doi: 10.3899/jrheum.2024-0723.
    PubMed    
    
    
    
38. HITCHON CA, El-Gabalawy HS
    Rheumatoid Arthritis Treatment Has Changed Dramatically Over the Past 3 Decades, but Has the Disease Itself Changed?
    J Rheumatol. 2024 Dec 15:jrheum.2024-1160. doi: 10.3899/jrheum.2024-1160.
    PubMed    
    
    
    
39. NOSSENT J, Keen HI, Preen DB, Inderjeeth CA, et al
    Cancer incidence and outcome for patients with Rheumatoid Arthritis: a long-term population study in Western Australia.
    J Rheumatol. 2024 Dec 15:jrheum.2024-0724. doi: 10.3899/jrheum.2024-0724.
    PubMed     Abstract available
    
    
    
40. LEONG KP, Yong MY, Koh ET, Cheung PPM, et al
    Exome sequencing of Singapore Chinese anti-citrullinated-protein-antibody-positive rheumatoid arthritis patients.
    J Rheumatol. 2024 Dec 1:jrheum.2024-0140. doi: 10.3899/jrheum.2024-0140.
    PubMed     Abstract available
    
    
    
41. LEE YC, Malfait AM, Ogdie AR
    Unmet Needs in Spondyloarthritis: Understanding and Managing Chronic Pain.
    J Rheumatol. 2024;51:1235-1240.
    PubMed     Abstract available
    
    
    
42. DEANE KD, Donlin LT, Ritchlin CT, Kuhn KA, et al
    Are There Disease Endotypes in Axial Spondyloarthritis and How Would We Define Them?
    J Rheumatol. 2024;51:1229-1234.
    PubMed     Abstract available
    
    
    November 2024
43. SUGAWARA E, Ninagawa K, Katsumata K
    Infected Tumoral Calcinosis Associated With Rheumatoid Arthritis.
    J Rheumatol. 2024 Nov 1:jrheum.2024-0761. doi: 10.3899/jrheum.2024-0761.
    PubMed     Abstract available
    
    
    
44. PROVAN SA, Ljung L, Kristianslund EK, Michelsen B, et al
    Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic Registries.
    J Rheumatol. 2024;51:1111-1118.
    PubMed     Abstract available
    
    
    October 2024
45. GIBLON RE, Achenbach SJ, Myasoedova E, Davis JM 3rd, et al
    Rising? trends in Anxiety and Depression among Individuals with Rheumatoid Arthritis: A Population-Based Study.
    J Rheumatol. 2024 Oct 15:jrheum.2024-0165. doi: 10.3899/jrheum.2024-0165.
    PubMed     Abstract available
    
    
    
46. RYDHOLM M, Hagel S, Jacobsson LTH, Turesson C, et al
    Disability Related to the Upper Extremities in Early Rheumatoid Arthritis - Long-term Course and Disease Parameter Impact: a cohort study.
    J Rheumatol. 2024 Oct 15:jrheum.2024-0608. doi: 10.3899/jrheum.2024-0608.
    PubMed     Abstract available
    
    
    
47. YANG T, Soto Gamez AA, Terpstra JH, Bootsma H, et al
    Cell Composition Analysis of Matched Salivary Organoid and Adherent Cultures: Choose Your Sjogren Disease Research Tool Carefully.
    J Rheumatol. 2024;51:1044-1046.
    PubMed    
    
    
    
48. PIANAROSA E, Roach P, Barber CEH, Holroyd BR, et al
    Deciding to Attend the Emergency Department: Experiences of Patients With Inflammatory Arthritis.
    J Rheumatol. 2024;51:1015-1022.
    PubMed     Abstract available
    
    
    September 2024
49. CARRIER N, Roux S, Masetto A, De Brum Fernandes AJ, et al
    Early Rheumatoid Arthritis Patients at Presentation Are Changing: A 24-Year Study of the Early Undifferentiated PolyArthritis (EUPA) Cohort.
    J Rheumatol. 2024 Sep 15:jrheum.2024-0560. doi: 10.3899/jrheum.2024-0560.
    PubMed     Abstract available
    
    
    
50. LIU S, Hu R
    Evaluating and Refining Strategies for Rheumatoid Arthritis Prevention in First Nations Communities.
    J Rheumatol. 2024 Sep 15:jrheum.2024-0726. doi: 10.3899/jrheum.2024-0726.
    PubMed     Abstract available
    
    
    August 2024
51. LEE J, Barber C, Jung M, Kaminska E, et al
    Decision Aid-Led Tapering of Biologic and Targeted Synthetic DMARDs in Rheumatoid Arthritis: A Qualitative Study.
    J Rheumatol. 2024 Aug 15:jrheum.2024-0383. doi: 10.3899/jrheum.2024-0383.
    PubMed     Abstract available
    
    
    
52. RODRIGUEZ-GONZALEZ D, Garcia-Gonzalez M, Gomez-Bernal F, Quevedo-Abeledo JC, et al
    Understanding the role of the complement system in insulin resistance and metabolic syndrome in patients with rheumatoid arthritis.
    J Rheumatol. 2024 Aug 1:jrheum.2024-0437. doi: 10.3899/jrheum.2024-0437.
    PubMed     Abstract available
    
    
    
53. MORRISON T, Gottman M, Do T, Rosenbaum JT, et al
    Scleritis and Development of Immune-Mediated Disease: A Retrospective Chart Review.
    J Rheumatol. 2024;51:825-830.
    PubMed     Abstract available
    
    
    July 2024
54. NIKOLIC RPA, Pardo Pardo J, Pope JE, Barber CEH, et al
    Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2.
    J Rheumatol. 2024 Jul 15:jrheum.2024-0540. doi: 10.3899/jrheum.2024-0540.
    PubMed     Abstract available
    
    
    
55. EL-GABALAWY H
    The Impact of Rheumatoid Arthritis on First Nations and How We Can Work With Communities to Prevent It.
    J Rheumatol. 2024;51.
    PubMed     Abstract available
    
    
    
56. TAYLOR PC
    The Rheumatoid Arthritis Impact of Disease (RAID) Score in Telemedicine Management of Rheumatoid Arthritis.
    J Rheumatol. 2024 Jul 1:jrheum.2024-0579. doi: 10.3899/jrheum.2024-0579.
    PubMed     Abstract available
    
    
    
57. VASSILAKI M, Jose George R, Kumar R, Lovering E, et al
    Validation of Different Dementia Code-based Definitions in a Population-based Study of Rheumatoid Arthritis.
    J Rheumatol. 2024 Jul 1:jrheum.2024-0299. doi: 10.3899/jrheum.2024-0299.
    PubMed     Abstract available
    
    
    
58. TARANNUM S, Widdifield J, Wu CF, Johnson SR, et al
    Sex-Related Differences in Dispensation of Rheumatic Medications in Older Patients With Inflammatory Arthritis: A Population-Based Study.
    J Rheumatol. 2024;51:703-707.
    PubMed     Abstract available
    
    
    
59. VISSER A, van Nimwegen JF, Wilbrink R, Liefers SC, et al
    Increased Interferon Signaling in Vaginal Tissue of Patients With Primary Sjogren Syndrome.
    J Rheumatol. 2024;51:687-695.
    PubMed     Abstract available
    
    
    June 2024
60. WEBER BN, Weisenfeld D, Jeffway M, Liu F, et al
    The Association Between High-Sensitivity Cardiac Troponin T and Major Adverse Cardiovascular Events in Rheumatoid Arthritis.
    J Rheumatol. 2024 Jun 15:jrheum.2024-0168. doi: 10.3899/jrheum.2024-0168.
    PubMed     Abstract available
    
    
    
61. AVOUAC J, Molto A, Allanore Y
    Evaluation of the RAID Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation.
    J Rheumatol. 2024 Jun 1:jrheum.2024-0143. doi: 10.3899/jrheum.2024-0143.
    PubMed     Abstract available
    
    
    
62. SUBDAR S, Dhiman K, Hartfeld NMS, Hoens AM, et al
    Investigating the Influence of Patient Eligibility Characteristics on the Number of Deferrable Rheumatologist Visits: Planning for a Patient-Initiated Follow-Up Strategy.
    J Rheumatol. 2024;51:587-595.
    PubMed     Abstract available
    
    
    May 2024
63. SMITH ID, Solomon MJ, Mulder H, Sims C, et al
    Evaluating factors associated with telehealth appropriateness in outpatient rheumatoid arthritis encounters using the Encounter Appropriateness Score for You (EASY).
    J Rheumatol. 2024 May 15:jrheum.2024-0014. doi: 10.3899/jrheum.2024-0014.
    PubMed     Abstract available
    
    
    
64. ORMSETH MJ, Oeser AM, Chung CP, Stein CM, et al
    Ambulatory blood pressure in patients with rheumatoid arthritis: association with immune activation.
    J Rheumatol. 2024 May 15:jrheum.2024-0205. doi: 10.3899/jrheum.2024-0205.
    PubMed     Abstract available
    
    
    
65. RYDELL E, Jacobsson LTH, Turesson C
    Circulating interleukin 17A and other inflammatory proteins may predict cardiovascular disease in early rheumatoid arthritis.
    J Rheumatol. 2024 May 1:jrheum.2023-1078. doi: 10.3899/jrheum.2023-1078.
    PubMed     Abstract available
    
    
    
66. EL-GABALAWY H
    The Impact of Rheumatoid Arthritis on First Nations and How We Can Work With Communities to Prevent It.
    J Rheumatol. 2024 May 1:jrheum.2024-0369. doi: 10.3899/jrheum.2024-0369.
    PubMed     Abstract available
    
    
    
67. MITTINTY MM, Mittinty MN, Buchbinder R, Lassere M, et al
    Interpersonal process of dyadic coping in rheumatoid arthritis: a perspective from the Australian Rheumatology Association Database (ARAD).
    J Rheumatol. 2024 May 1:jrheum.2023-0664. doi: 10.3899/jrheum.2023-0664.
    PubMed     Abstract available
    
    
    
68. RUSCITTI P, McGonagle D, Garcia VC, Rabijns H, et al
    Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs.
    J Rheumatol. 2024;51:442-451.
    PubMed     Abstract available
    
    
    April 2024
69. BURMESTER GR, Van den Bosch F, Tesser J, Shmagel A, et al
    Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT).
    J Rheumatol. 2024 Apr 15:jrheum.2023-1062. doi: 10.3899/jrheum.2023-1062.
    PubMed     Abstract available
    
    
    
70. RAMSAY D, Taylor T
    Does Changing Anticyclic Citrullinated Protein Testing From Restricted Ordering to Open Ordering Affect Healthcare Utilization and the Rate of Positive Testing?
    J Rheumatol. 2024;51:432-433.
    PubMed    
    
    
    
71. EVIATAR T, Furer V, Polachek A, Zisman D, et al
    Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls.
    J Rheumatol. 2024;51:415-422.
    PubMed     Abstract available
    
    
    March 2024
72. SUBDAR S, Hoens AM, White K, Hartfeld NMS, et al
    An environmental scan and appraisal of patient online resources for managing rheumatoid arthritis flares.
    J Rheumatol. 2024 Mar 15:jrheum.2023-1025. doi: 10.3899/jrheum.2023-1025.
    PubMed     Abstract available
    
    
    
73. WIENS D, Smolik IA, MacKay D, Fowler-Woods A, et al
    Perceived Access to Health Care of Indigenous Peoples in Canada with Rheumatoid Arthritis and their First-Degree Relatives.
    J Rheumatol. 2024 Mar 1:jrheum.2023-1080. doi: 10.3899/jrheum.2023-1080.
    PubMed     Abstract available
    
    
    
74. FONG KTD, Sng WJ, Lee KMV, Tan HSA, et al
    A Familiar Face in an Unfamiliar Place: Intraosseous Rheumatoid Nodule.
    J Rheumatol. 2024;51:314-315.
    PubMed    
    
    
    February 2024
75. PAPPAS DA, O'Brien J, Moore PC, Dodge R, et al
    Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results from the CorEvitas Rheumatoid Arthritis Registry.
    J Rheumatol. 2024 Feb 15:jrheum.2023-0752. doi: 10.3899/jrheum.2023-0752.
    PubMed     Abstract available
    
    
    
76. WIERCZEIKO A, Linke M, Friedrich JP, Koch J, et al
    A Call for Gene Expression Analysis in Whole Blood of Patients With Rheumatoid Arthritis (RA) as a Biomarker for RA-Associated Interstitial Lung Disease.
    J Rheumatol. 2024;51:130-133.
    PubMed     Abstract available
    
    
    
77. KRISTENSEN S, Hagelskjaer AM, Cordtz R, Bliddal S, et al
    Polyautoimmunity in patients with anti-cyclic citrullinated peptide antibody-positive and -negative rheumatoid arthritis: a nationwide cohort study from Denmark.
    J Rheumatol. 2024 Feb 1:jrheum.2023-0907. doi: 10.3899/jrheum.2023-0907.
    PubMed     Abstract available
    
    
    
78. GONZALEZ-GAY MA, Castaneda S, Ferraz-Amaro I
    Metabolic Syndrome: A Predisposing Factor for Rheumatoid Arthritis.
    J Rheumatol. 2024 Feb 1:jrheum.2023-1210. doi: 10.3899/jrheum.2023-1210.
    PubMed     Abstract available
    
    
    
79. HEMGREN C, Martinsson K, Rooney C, Wettero J, et al
    Elevated Serum Levels of Zonulin Family Peptides in Anticitrullinated Protein Antibody-Positive At-Risk Individuals Without Arthritis.
    J Rheumatol. 2024;51:134-138.
    PubMed     Abstract available
    
    
    
80. FARRER C, Thib S, Eder L, Jerome D, et al
    Use of Coordinator Role Improves Access to Rheumatologic Advanced Therapy.
    J Rheumatol. 2024;51:197-202.
    PubMed     Abstract available
    
    
    January 2024
81. O'NEIL LJ, Alpizar-Rodriguez D, Deane KD
    Rheumatoid arthritis: The continuum of disease and strategies for prediction, early intervention and prevention.
    J Rheumatol. 2024 Jan 15:jrheum.2023-0334. doi: 10.3899/jrheum.2023-0334.
    PubMed     Abstract available
    
    
    
82. STAMP LK, Keating P, Frampton C, Barclay ML, et al
    Relationship between adalimumab concentrations, anti-drug antibodies and disease activity in rheumatoid arthritis: a cross-sectional observational study.
    J Rheumatol. 2024 Jan 15:jrheum.2023-0706. doi: 10.3899/jrheum.2023-0706.
    PubMed     Abstract available
    
    
    
83. LUO P, Xu W, Ye D, Chen W, et al
    Metabolic Syndrome Is Associated With an Increased Risk of Rheumatoid Arthritis: A Prospective Cohort Study Including 369,065 Participants.
    J Rheumatol. 2024 Jan 15:jrheum.2023-0349. doi: 10.3899/jrheum.2023-0349.
    PubMed     Abstract available
    
    
    December 2023
84. ZHUO N, Wang G, Wu G
    The Incidence of Herpes Zoster Is Increased in the Population of Patients With Rheumatoid Arthritis.
    J Rheumatol. 2023 Dec 1:jrheum.2023-0249. doi: 10.3899/jrheum.2023-0249.
    PubMed     Abstract available
    
    
    November 2023
85. POSIO C, Suardi I, Caporali R, Ingegnoli F, et al
    Owning Pets Reduces the Perception of Disease Activity in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2023 Nov 15:jrheum.2023-0950. doi: 10.3899/jrheum.2023-0950.
    PubMed     Abstract available
    
    
    
86. NOWELL WB, Barnes EL, Venkatachalam S, Kappelman MD, et al
    Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network.
    J Rheumatol. 2023;50:1503-1508.
    PubMed     Abstract available
    
    
    
87. MURAYAMA A
    Industry-Sponsored Research Funding to Rheumatologists in the United States Between 2014 and 2022.
    J Rheumatol. 2023;50:1510-1513.
    PubMed    
    
    
    
88. INANC N, Jousse-Joulin S, Abacar K, Cimsit C, et al
    The novel OMERACT Ultrasound Scoring System for salivary glands changes in patients with Sjogren's syndrome is associated with MRI and salivary flow rates.
    J Rheumatol. 2023 Nov 1:jrheum.2023-0202. doi: 10.3899/jrheum.2023-0202.
    PubMed     Abstract available
    
    
    October 2023
89. KWON HC, Kang MI, Kim SM
    Cystatin C as a Predictor of Renal function and Methotrexate-associated toxicities in Patients with Rheumatoid arthritis.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0218. doi: 10.3899/jrheum.2023-0218.
    PubMed     Abstract available
    
    
    
90. LEE JJY, Bernatsky S, Kwong JC, Li Q, et al
    Safety and Health Care Utilization following COVID-19 Vaccination among Adults with Rheumatoid Arthritis - A population-based self-controlled case series analysis.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0355. doi: 10.3899/jrheum.2023-0355.
    PubMed     Abstract available
    
    
    
91. KWOK TSH, Kuriya B, Eder L, Aghanya V, et al
    Low Nirmatrelvir/Ritonavir Use Among Patients With Rheumatoid Arthritis: A Signal of Concern.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0439. doi: 10.3899/jrheum.2023-0439.
    PubMed     Abstract available
    
    
    
92. CHANG YH, Buras MR, Davis JM 3rd, Crowson CS, et al
    Avoiding Blunders When Analyzing Correlated Data, Clustered Data, or Repeated Measures.
    J Rheumatol. 2023;50:1269-1272.
    PubMed     Abstract available
    
    
    
93. ISLAM ST, Descallar J, Martens D, Hassett G, et al
    Screening for Anxiety in Patients With Inflammatory Arthritis Using the Multidimensional Health Assessment Questionnaire.
    J Rheumatol. 2023;50:1273-1278.
    PubMed     Abstract available
    
    
    
94. SHRIDHARMURTHY D, Lapane KL, Nunes AP, Baek J, et al
    Postpartum Depression in Reproductive-Age Women With and Without Rheumatic Disease: A Population-Based Matched Cohort Study.
    J Rheumatol. 2023;50:1287-1295.
    PubMed     Abstract available
    
    
    September 2023
95. BARTON JL
    Unequal Treatment: Physical Therapy Utilization in Rheumatoid Arthritis.
    J Rheumatol. 2023 Sep 15:jrheum.2023-0814. doi: 10.3899/jrheum.2023-0814.
    PubMed     Abstract available
    
    
    
96. VISMAN I, Atiqi S, Boers M, Twisk J, et al
    Changes in TNF inhibitor drug survival in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis over 15 years.
    J Rheumatol. 2023 Sep 15:jrheum.2023-0149. doi: 10.3899/jrheum.2023-0149.
    PubMed     Abstract available
    
    
    
97. BRYNJARSDOTTIR HB, Bjursten S, Levin M, Gjertsson I, et al
    Successful Management of Checkpoint Inhibitor-Induced Arthritis With Disease-Modifying Antirheumatic Drugs During Active Immune Checkpoint Inhibition Treatment.
    J Rheumatol. 2023;50:1195-1197.
    PubMed    
    
    
    
98. YAMAMOTO K, Rokutanda R
    Disseminated Mycobacterium haemophilum Infection Mimicking Rheumatoid Nodules.
    J Rheumatol. 2023;50:1193.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.